Tahari, Albaser M.

HRN: 22-71-58  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/11/2025
10/17/2025
IV
350mg
Q6
PCAP C
Checking Final Appropriateness 
10/14/2025
CEFUROXIME 750MG (VIAL)
10/14/2025
10/21/2025
IV
375mg
Every 8hours
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: